Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
Commodore Capital LP reported a 5.10% stake in Amylyx Pharmaceuticals, Inc. (Schedule 13G)
Event Nov 10, 2025 · Filed Nov 17, 2025
Commodore Capital LP reported a 5.10% stake in Amylyx Pharmaceuticals, Inc., 5,650,000 shares, as a passive investor on Nov 10, 2025. Filed Nov 17, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 5,650,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 5.10% | 5,650,000 |
| Commodore Capital Master LP | 5.10% | 5,650,000 |
| Robert Egen Atkinson | 5.10% | 5,650,000 |
| Michael Kramarz | 5.10% | 5,650,000 |